Russell Investments Group, Ltd. Avrobio, Inc. Transaction History

Russell Investments Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	SELL	$1.29 - $4.04 $43,505 - $136,249	-33,725 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$3.45 - $6.05 $39,160 - $68,673	-11,351 Reduced 25.18%	33,725 $129,000
Q3 2021 Nov 08, 2021	SELL	$5.53 - $9.28 $2,228 - $3,739	-403 Reduced 0.89%	45,076 $251,000
Q2 2021 Aug 04, 2021	SELL	$7.84 - $12.6 $33,272 - $53,474	-4,244 Reduced 8.54%	45,479 $403,000
Q1 2021 May 10, 2021	BUY	$10.54 - $19.3 $494,568 - $905,613	46,923 Added 1675.82%	49,723 $630,000
Q4 2020 Feb 08, 2021	BUY	$12.79 - $17.1 $35,812 - $47,880	2,800 New	2,800 $39,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.